Responses
Haematology (incl blood transfusion)
Protocol
Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study)
Compose a Response to This Article
Other responses
No responses have been published for this article.